vs

Side-by-side financial comparison of Evercore Inc. (EVR) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.4B, roughly 1.5× Evercore Inc.). Evercore Inc. runs the higher net margin — 23.0% vs 11.4%, a 11.6% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (100.3% vs 9.3%). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (42.2% CAGR vs 3.7%).

Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

EVR vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.5× larger
ZBH
$2.1B
$1.4B
EVR
Growing faster (revenue YoY)
EVR
EVR
+91.0% gap
EVR
100.3%
9.3%
ZBH
Higher net margin
EVR
EVR
11.6% more per $
EVR
23.0%
11.4%
ZBH
Faster 2-yr revenue CAGR
EVR
EVR
Annualised
EVR
42.2%
3.7%
ZBH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EVR
EVR
ZBH
ZBH
Revenue
$1.4B
$2.1B
Net Profit
$322.7M
$238.3M
Gross Margin
64.6%
Operating Margin
17.9%
Net Margin
23.0%
11.4%
Revenue YoY
100.3%
9.3%
Net Profit YoY
106.1%
30.5%
EPS (diluted)
$7.20
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVR
EVR
ZBH
ZBH
Q1 26
$1.4B
$2.1B
Q4 25
$1.3B
$2.2B
Q3 25
$1.0B
$2.0B
Q2 25
$838.0M
$2.1B
Q1 25
$699.0M
$1.9B
Q4 24
$979.5M
$2.0B
Q3 24
$738.4M
$1.8B
Q2 24
$693.4M
$1.9B
Net Profit
EVR
EVR
ZBH
ZBH
Q1 26
$322.7M
$238.3M
Q4 25
$204.0M
$139.4M
Q3 25
$144.6M
$230.9M
Q2 25
$97.2M
$152.8M
Q1 25
$146.2M
$182.0M
Q4 24
$140.4M
$239.5M
Q3 24
$78.4M
$249.1M
Q2 24
$73.8M
$242.8M
Gross Margin
EVR
EVR
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
EVR
EVR
ZBH
ZBH
Q1 26
17.9%
Q4 25
24.2%
6.9%
Q3 25
20.8%
17.6%
Q2 25
18.0%
14.4%
Q1 25
16.0%
15.3%
Q4 24
21.8%
19.2%
Q3 24
16.7%
15.3%
Q2 24
15.9%
18.1%
Net Margin
EVR
EVR
ZBH
ZBH
Q1 26
23.0%
11.4%
Q4 25
15.7%
6.2%
Q3 25
13.8%
11.5%
Q2 25
11.6%
7.4%
Q1 25
20.9%
9.5%
Q4 24
14.3%
11.8%
Q3 24
10.6%
13.7%
Q2 24
10.6%
12.5%
EPS (diluted)
EVR
EVR
ZBH
ZBH
Q1 26
$7.20
$1.22
Q4 25
$4.80
$0.71
Q3 25
$3.41
$1.16
Q2 25
$2.36
$0.77
Q1 25
$3.48
$0.91
Q4 24
$3.32
$1.18
Q3 24
$1.86
$1.23
Q2 24
$1.81
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVR
EVR
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$12.7B
Total Assets
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVR
EVR
ZBH
ZBH
Q1 26
$424.2M
Q4 25
$3.0B
$591.9M
Q3 25
$2.4B
$1.3B
Q2 25
$1.7B
$556.9M
Q1 25
$1.4B
$1.4B
Q4 24
$2.4B
$525.5M
Q3 24
$1.8B
$569.0M
Q2 24
$1.7B
$420.1M
Total Debt
EVR
EVR
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
EVR
EVR
ZBH
ZBH
Q1 26
$12.7B
Q4 25
$2.0B
$12.7B
Q3 25
$1.8B
$12.8B
Q2 25
$1.7B
$12.5B
Q1 25
$1.5B
$12.4B
Q4 24
$1.7B
$12.5B
Q3 24
$1.6B
$12.4B
Q2 24
$1.5B
$12.7B
Total Assets
EVR
EVR
ZBH
ZBH
Q1 26
$22.7B
Q4 25
$5.4B
$23.1B
Q3 25
$4.4B
$23.5B
Q2 25
$3.7B
$22.9B
Q1 25
$3.3B
$22.2B
Q4 24
$4.2B
$21.4B
Q3 24
$3.6B
$21.7B
Q2 24
$3.3B
$21.5B
Debt / Equity
EVR
EVR
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVR
EVR
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVR
EVR
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$807.5M
$517.4M
Q3 25
$560.9M
$418.7M
Q2 25
$437.7M
$378.2M
Q1 25
$-549.7M
$382.8M
Q4 24
$686.4M
$506.3M
Q3 24
$234.5M
$395.7M
Q2 24
$348.5M
$369.4M
Free Cash Flow
EVR
EVR
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$798.6M
$442.6M
Q3 25
$541.5M
$363.7M
Q2 25
$411.7M
$328.1M
Q1 25
$-569.3M
$338.2M
Q4 24
$673.1M
$454.8M
Q3 24
$226.6M
$351.2M
Q2 24
$340.7M
$316.7M
FCF Margin
EVR
EVR
ZBH
ZBH
Q1 26
11.8%
Q4 25
61.6%
19.7%
Q3 25
51.8%
18.2%
Q2 25
49.1%
15.8%
Q1 25
-81.4%
17.7%
Q4 24
68.7%
22.5%
Q3 24
30.7%
19.3%
Q2 24
49.1%
16.3%
Capex Intensity
EVR
EVR
ZBH
ZBH
Q1 26
Q4 25
0.7%
3.3%
Q3 25
1.9%
2.7%
Q2 25
3.1%
2.4%
Q1 25
2.8%
2.3%
Q4 24
1.4%
2.5%
Q3 24
1.1%
2.4%
Q2 24
1.1%
2.7%
Cash Conversion
EVR
EVR
ZBH
ZBH
Q1 26
1.51×
Q4 25
3.96×
3.71×
Q3 25
3.88×
1.81×
Q2 25
4.50×
2.48×
Q1 25
-3.76×
2.10×
Q4 24
4.89×
2.11×
Q3 24
2.99×
1.59×
Q2 24
4.72×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVR
EVR

Advisory Fees (1)$1.2B89%
Commissions and Related Revenue$62.7M4%
Underwriting Fees$55.1M4%
Asset Management and Administration Fees (2)$23.7M2%
Other Revenue, net$15.4M1%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons